, Tracking Stock Market Picks
Enter Symbol:
Allergan, Inc. (AGN) [hlAlert]

up 62.20 %

Allergan, Inc. (AGN) upgraded to Buy with price target $215 by Deutsche Bank

Posted on: Thursday,  Oct 9, 2014  3:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy Allergan, Inc. (NYSE: AGN) on 10/09/2014, when the stock price was $188.64. Since
then, Allergan, Inc. has gained 62.20% as of 11/24/2015's recent price of $305.98.
If you would have followed this Deutsche Bank's recommendation on AGN, you would have gained 62.2% of your investment in 411 days.

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company is engaged in discovering, developing and commercializing specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries globally. In January 2007, the Company completed the acquisition of Groupe Corneal Laboratoires (Corneal). In October 2007, the Company completed the acquisition of Esprit Pharma Holding Company, Inc. (Esprit). In July 2008, the Company acquired the Aczone (dapsone) gel 5% from QLT USA, Inc. (QLT), a wholly owned subsidiary of QLT Inc. The Company operates in two business segments: specialty pharmaceuticals and medical devices.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/9/2014 3:25 PM Buy
188.64 215.00
as of 10/17/2014
1 Week down  -5.39 %
1 Month down  -5.91 %
3 Months down  -5.91 %
1 YTD down  -5.91 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/24/2013 2:25 PM Hold
9/16/2011 2:25 PM Buy
82.71 97.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy